Skip to main content
Caplight Logo









CIPRA.ai

CIPRA.ai

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://cipra.ai/

Last Round

Accelerator

Sep 1, 2025

Total Funding Raised

$1.22M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CIPRA.ai is a healthcare technology company that has developed a healthcare management software platform designed to support chronic disease care through individualized modeling and continuous monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Patient Engagement, Health IoT

Business Model

B2B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

digital twinchronic condition managementAI health coachinghypertension managementdiabetes managementremote patient monitoringmedical AIprecision medicinechronic care platformpersonalized health recommendationsvirtual careagentic AIdigital health platformpatient engagementB2B2C modelwearable data integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CIPRA.ai Comparables

Compare CIPRA.ai with similar companies based on industry and business-model similarity.

CIPRA.ai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Center Health
84%
Thrive AI Health
80%
Welldoc
78%

CIPRA.ai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 1, 2025
SeedSep 12, 2023

CIPRA.ai Investors

Notable investors and investment history

CIPRA.ai investors
InvestorRounds
TechstarsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 10, 2026

    Open roles increased to 5, 2.5x the trailing average.

  • Jul 28, 2026

    Monthly visitors grew 75% MoM.

Recent news

Latest coverage and updates

  • is_developingSep 22, 2026

    CIPRA.ai is developing AI-powered medical wearables on Sep 1st '26.

  • partners_withSep 21, 2026

    CIPRA.ai partnered with Murata Manufacturing Co. on Sep 21st '26.

CIPRA.ai Filings

Explore SEC and related filing metadata, where available.

CIPRA.ai filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CIPRA.ai's valuation, stock price, and market status.

Is CIPRA.ai a public or private company?

CIPRA.ai is a private company.

What is the current stock price of CIPRA.ai?

CIPRA.ai is a private company with no public stock price. No recent secondary market data is available.

How much is CIPRA.ai worth (valuation)?

Valuation information for CIPRA.ai is not publicly available.

Can I buy CIPRA.ai stock?

CIPRA.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CIPRA.ai's last funding round?

Funding round information for CIPRA.ai is not publicly available.

Who are the main investors in CIPRA.ai?

Investor information for CIPRA.ai is not publicly disclosed.

Will CIPRA.ai IPO soon?

No public IPO plans have been announced for CIPRA.ai.

How can I track CIPRA.ai secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CIPRA.ai's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range16
Year Founded2022
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?